This article was originally published in The Gray Sheet
Executive SummaryOrthopedic firm gains access to the spinal implant market via an exclusive three-year U.S. distribution agreement with Paris-based spinal implant maker Scient'x, Encore reports Oct. 30. FDA clearance for the firm's Isolock-Isobar rigid fixation system is expected in "early 1999." Other offerings from Scient'x needing a nod from FDA include the PCB cervical plate system for anterior fusion of the cervical spine and the Isomorphic lumbar cage system
You may also be interested in...
Roughly 18.5% of patients who received reinterventions to fix mesh implants for pelvic organ prolapse (POP) repair experienced complications they will likely endure for the rest of their lives, and they also face a 2.5% higher rate of further surgeries than non-mesh patients, says a recent 54,194-woman study detailed in Obstetrics & Gynecology. The study authors lay out a case that the US FDA should have forced removal of mesh from the market sooner.
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.